ISRT 20 Gy for Indolent Localized Gastrointestinal (GI)-Lymphoma
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital Muenster
About this trial
This trial studies the effectivity of low-dose radiation therapy with 10x2Gy for the treatment of patients with stage I-II stomach or duodenal Lymphoma (Marginal Zone or Follicular)
Eligibility criteria
Qualifiers
primary indolent gastric or duodenal lymphoma
pathology: marginal zone lymphoma (MZL) or follicular lymphoma (FL)
stage: clinical stage I or II (Ann Arbor classification)
H. pylori negative or antibiotic resistant lymphoma
Disqualifiers
prior radiation treatment of the gastrointestinal lymphoma
stage: clinical stage III or IV (Ann Arbor classification)-unability to understand the informed consent or unwillingness to participate in the study
severe comorbidity or organ dysfunction contraindicating the use of RT (liver cirrhosis Child-Pugh C, chronic obstructive pulmonary disease GOLD 4, heart insufficiency NYHA IV, dialysis dependent renal insufficiency, uncontrolled epilepsy)
known seropositivity for HIV
Trial design
Treatments tested in this trial
- Radiation Therapy
Treatment groups
83 Participants
are divided into 1 treatment groupSponsors and collaborators
University Hospital Muenster
Lead sponsor
International Lymphoma Radiation Oncology Group (ILROG)
Collaborator
Source ClinicalTrials.gov